MedTrace Logo

A Clinical Investigation of the C2a-Taper™ Acetabular System

NCT00578851 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2017-06-21

No results posted yet for this study

Summary

The objective of this study is to gather clinical and survivorship information for the C2a-Taper™ Acetabular System, a ceramic-on-ceramic hip articulating system.

Conditions

  • Osteoarthritis
  • Avascular Necrosis
  • Congenital Hip Dysplasia
  • Traumatic Arthritis

Interventions

DEVICE

C2a - Taper™ Acetabular System

The C2a-Taper™ Acetabular System is a ceramic on ceramic hip articulating system. The bearing surfaces consist of ceramic femoral heads and acetabular liners.

Sponsors & Collaborators

  • Biomet Orthopedics, LLC

    lead INDUSTRY

Principal Investigators

  • Kara Mezger · Zimmer Biomet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2014-10-31
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00578851 on ClinicalTrials.gov